5 D Health Protection Group

Executive Summary

5 D Health Protection Group Ltd is a UK-based contract research organization (CRO) and microbiology laboratory that specializes in biofilm science, antimicrobial testing, and infection control. Founded in 2020 and headquartered in London, the company leverages over 28 years of collective experience to provide bespoke scientific testing, consultancy, and research services. Its primary clients are in medical devices, wound care, and other regulated sectors, where it supports product development and regulatory submissions. By focusing on biofilm-related challenges, 5 D Health Protection Group addresses a critical niche in infection prevention, offering expertise that is increasingly important as antimicrobial resistance grows and regulatory requirements tighten. The company operates in the digital health and AI/machine learning categories, although its core services are laboratory-based. Its position as a specialized CRO gives it opportunities to partner with larger medical device firms and wound care companies seeking validated testing and regulatory support. With no disclosed funding or valuation, 5 D Health Protection Group appears to be an early-stage private firm. Its growth will depend on securing repeat contracts, expanding its client base, and potentially developing proprietary testing methodologies. The rising focus on infection control in healthcare settings provides a tailwind, making the company well-placed to capture market share in the antimicrobial testing and biofilm analysis space.

Upcoming Catalysts (preview)

• Q4 2026Securing a major contract with a top medical device manufacturer for biofilm testing services40% success
• Q1 2027Publication of a validation study demonstrating a novel antimicrobial testing protocol60% success
• Q2 2027Expansion into the pharmaceutical sector for drug-device combination product testing30% success